[HTML][HTML] Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4–19 years with epilepsy: a real-world study
SE Youn, HC Kang, JS Lee, HD Kim, SH Kim - Scientific reports, 2023 - nature.com
This study determined the 24-month outcomes of perampanel treatment in children and
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
[HTML][HTML] Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4–19 years with epilepsy: a real-world study
SE Youn, HC Kang, JS Lee, HD Kim, SH Kim - Scientific Reports, 2023 - ncbi.nlm.nih.gov
This study determined the 24-month outcomes of perampanel treatment in children and
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4–19 years with epilepsy: a real-world study
S Youn, H Kang, J Lee, H Kim, S Kim - Scientific Reports, 2023 - europepmc.org
This study determined the 24-month outcomes of perampanel treatment in children and
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4–19 years with epilepsy: a real-world study.
SE Youn, HC Kang, JS Lee, HD Kim… - Scientific …, 2023 - search.ebscohost.com
This study determined the 24-month outcomes of perampanel treatment in children and
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4-19 years with epilepsy: a real-world study
SE Youn, HC Kang, JS Lee, HD Kim… - Scientific …, 2023 - ui.adsabs.harvard.edu
This study determined the 24-month outcomes of perampanel treatment in children and
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4–19 years with epilepsy: a real-world study
SE Youn, HC Kang, JS Lee, HD Kim… - Scientific …, 2023 - yonsei.elsevierpure.com
This study determined the 24-month outcomes of perampanel treatment in children and
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4-19 years with epilepsy: a real-world study
SE Youn, HC Kang, JS Lee, HD Kim… - Scientific …, 2023 - pubmed.ncbi.nlm.nih.gov
This study determined the 24-month outcomes of perampanel treatment in children and
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4-19 years with epilepsy: a real-world study.
SE Youn, HC Kang, JS Lee, HD Kim, SH Kim - Scientific Reports, 2023 - europepmc.org
This study determined the 24-month outcomes of perampanel treatment in children and
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …
adolescents with epilepsy. The percentage of≥ 50% responders was 47.3%(139/294) at 12 …